Yasuhiro Egi

546 total citations
18 papers, 465 citations indexed

About

Yasuhiro Egi is a scholar working on Nephrology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yasuhiro Egi has authored 18 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Physiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yasuhiro Egi's work include Nitric Oxide and Endothelin Effects (4 papers), Renin-Angiotensin System Studies (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Yasuhiro Egi is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Renin-Angiotensin System Studies (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Yasuhiro Egi collaborates with scholars based in Japan, United States and United Kingdom. Yasuhiro Egi's co-authors include Yasuo Matsumura, Eng H. Lo, Ken Arai, Kazutaka Hayashi, Masayoshi Uehata, Nobuharu Gotô, Masahide Nakajima, Takao Kondo, Brian J. Lee and Klaus van Leyen and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yasuhiro Egi

18 papers receiving 456 citations

Peers

Yasuhiro Egi

CCM

PHYSI

ONCOL

EPIDE

Elena Nobili Italy

Andrea Sovic Austria

Rui F. Simões Portugal

Daniel Franco United States

Francesca Ferrelli Italy

S Hubl United States

Simona‐Adriana Manea Romania

Simon Cuhlmann United Kingdom

Elena Nobili Italy

Yasuhiro Egi

189 ×1.0

121 ×1.2

CCM

71 ×0.8

PHYSI

26 ×0.3

ONCOL

80 ×1.4

EPIDE

Citations per year, relative to Yasuhiro Egi Yasuhiro Egi (= 1×) peers Elena Nobili

Countries citing papers authored by Yasuhiro Egi

Since Specialization

Citations

This map shows the geographic impact of Yasuhiro Egi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Egi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Egi more than expected).

Fields of papers citing papers by Yasuhiro Egi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Egi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Egi. The network helps show where Yasuhiro Egi may publish in the future.

Co-authorship network of co-authors of Yasuhiro Egi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Egi. A scholar is included among the top collaborators of Yasuhiro Egi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Egi. Yasuhiro Egi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sasaki, Wataru, et al.. (2018). Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2. Journal of Medicinal Chemistry. 61(13). 5594–5608. 18 indexed citations

Egi, Yasuhiro, et al.. (2015). Partial deletion of the ROCK2 protein fails to reduce renal fibrosis in a unilateral ureteral obstruction model in mice. Molecular Medicine Reports. 13(1). 231–236. 3 indexed citations

Egi, Yasuhiro, et al.. (2015). Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction. Molecular Medicine Reports. 12(6). 8010–8020. 32 indexed citations

Egi, Yasuhiro, et al.. (2011). MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model. Brain Research. 1410. 122–131. 34 indexed citations

Egi, Yasuhiro, et al.. (2011). Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia. Brain Research. 1389. 169–176. 21 indexed citations

Lee, Brian J., Yasuhiro Egi, Klaus van Leyen, Eng H. Lo, & Ken Arai. (2009). Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Research. 1307. 22–27. 66 indexed citations

Fujiwara, Norio, Yoshihiro Murata, Ken Arai, et al.. (2009). Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neuroscience. 10(1). 79–79. 30 indexed citations

Egi, Yasuhiro, Masashi Tawa, Ai Yamamoto, et al.. (2008). Angiotensin II Type 2 Receptor-Mediated Inhibition of Norepinephrine Release in Isolated Rat Hearts. Journal of Cardiovascular Pharmacology. 52(2). 176–183. 13 indexed citations

Nakajima, Masahide, Kazutaka Hayashi, Yasuhiro Egi, et al.. (2003). Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. European Journal of Pharmacology. 459(2-3). 113–120. 58 indexed citations

10.

Nakajima, Masahide, Kazutaka Hayashi, Yasuhiro Egi, et al.. (2003). Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma. Cancer Chemotherapy and Pharmacology. 52(4). 319–324. 70 indexed citations

11.

Hayashi, Kazutaka, Mamoru Koyama, Hideaki Kido, et al.. (1998). Preventive and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats. The Japanese Journal of Pharmacology. 76. 248–248. 2 indexed citations

12.

Hayashi, Kazutaka, Mamoru Koyama, Hideaki Kido, et al.. (1997). PREVENTATIVE AND THERAPEUTIC EFFECTS OF AE0047 ON RENAL INJURY IN STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 24(11). 831–840. 7 indexed citations

13.

Shinyama, Hiroshi, Tōru Kawamura, Yasuhiro Egi, et al.. (1997). Effects of the Calcium Antagonist AE0047 on the Development of Neurological Deficit and Infarction after Middle Cerebral Artery Occlusion in Stroke-prone Spontaneously Hypertensive Rats. Journal of Pharmacy and Pharmacology. 49(9). 919–924. 4 indexed citations

14.

Matsumura, Yasuo, et al.. (1996). Inhibitory Effects of Endothelin-3 on Antidiuresis and Norepinephrine Overflow Induced by Stimulation of Renal Nerves in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 28(2). 278–284. 14 indexed citations

15.

Egi, Yasuhiro, et al.. (1995). Enhancement of Norepinephrine and Angiotensin II-Induced Renal Effects by NG-Nitro-L-arginine, a Nitric Oxide Synthase Inhibitor.. Biological and Pharmaceutical Bulletin. 18(4). 496–500. 13 indexed citations

16.

Egi, Yasuhiro, et al.. (1995). Interaction Between Nitric Oxide and Angiotensin II on Antidiuresis and Norepinephrine Overflow Induced by Stimulation of Renal Nerves in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 25(2). 187–193. 9 indexed citations

17.

Egi, Yasuhiro, et al.. (1994). The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 269(2). 529–535. 45 indexed citations

18.

Suzuki, Yasunori, Yasuo Matsumura, Yasuhiro Egi, & Shinji Morimoto. (1992). Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 956–963. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact